Companies:
53,105
Total Market Cap:
170065083900481.13
Global Rank
#18706
Country Rank
#513
Market Cap
291.1 M
Price
10.12
Change (%)
1.89%
Volume
20,660
i-SENS's latest marketcap:
291.1 M
As of 07/17/2026, i-SENS's market capitalization has reached $291.1 M. According to our data, i-SENS is the 18706th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 291.1 M |
| Revenue (ttm) | 211.83 M |
| Net Income (ttm) | -3,905,587.85 |
| Shares Out | 28.76 M |
| EPS (ttm) | -0.14 |
| Forward PE | 94.47 |
| Ex-Dividend Date | 12/29/2025 |
| Earnings Date | 08/14/2026 |
Market Cap Chart
Data Updated: 07/17/2026
i-SENS's yearly market capitalization.
i-SENS has seen its market value drop from ₩574.17 B to ₩431.92 B since 2014, representing a total decrease of 24.77% and an annual compound decline rate (CAGR) of 2.44%.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/17/2026 | ₩431.92 B | $291.1 M | 6.39% | 18706 |
| 12/30/2025 | ₩438.95 B | $298.28 M | 4.01% | 16477 |
| 12/30/2024 | ₩422.03 B | $282.76 M | -46.36% | 16809 |
| 12/28/2023 | ₩786.74 B | $605.79 M | 74.15% | 11715 |
| 12/29/2022 | ₩451.77 B | $356.9 M | 9.85% | 14443 |
| 12/30/2021 | ₩411.25 B | $345.45 M | 0.83% | 15640 |
| 12/30/2020 | ₩407.85 B | $0 | 16.73% | 13269 |
| 12/30/2019 | ₩349.39 B | $300.48 M | 13.04% | 12756 |
| 12/28/2018 | ₩309.09 B | $275.09 M | -11.05% | 12286 |
| 12/28/2017 | ₩347.48 B | $323.15 M | -13.86% | 12555 |
Company Profile
About i-SENS, Inc.
i-SENS, Inc. is a South Korean company specializing in the development, manufacturing, and sale of chemical and biosensors. Founded in 2000 and headquartered in Seoul, the company serves both domestic and international markets.
Product Offerings
- Blood Glucose Monitoring Devices: Advanced solutions for diabetes management.
- Healthcare Devices: Includes diabetes care, acute care, and coagulation care products.
- Veterinary Care Devices: Specialized sensors for animal health monitoring.
- Accessory Products: Complementary tools for enhanced usability.
- SmartLog Software: Diabetes management platform for mobile and PC users.
With a focus on innovation, i-SENS continues to expand its portfolio to meet diverse healthcare needs globally.
Frequently Asked Questions
-
What is i-SENS's (KOSDAQ-099190) current market cap?As of 07/17/2026, i-SENS (including the parent company, if applicable) has an estimated market capitalization of $291.1 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does i-SENS (KOSDAQ-099190) rank globally by market cap?i-SENS global market capitalization ranking is approximately 18706 as of 07/17/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.